FDA Delay In Cancer Therapy  Is Attacked
277050
Oncologists do not usually need bodyguards when they present scientific data at a medical symposium.
44221
Novartis AG  cut its full-year results outlook as generic competition pressured sales of a key blood-pressure drug, and said U.S. regulators had delayed the approval process for an important cancer treatment.
59092
The FDA, which has been under criticism for its lengthy approval process, this week approved two new drugs for multiple sclerosis and cancer treatment.
589039
A long, suspicious delay in the study of Merck and Schering's $5 billion drug was reported by Forbes last November.
29666
While treatments have multiplied, the operations and processes for delivering those medicines haven't kept pace, slowing health improvement in developing and developed countries. Alexis Madrigal reports from the AAAS annual meeting in Boston.
563942
An "alarming" number of patients with suspected breast cancer wait too long for diagnosis, doctors warn.
578766
The company announces another slight delay with its lead drug.
695798
Yet another delay from the FDA leaves investors hanging.
609494
Scientists have launched a pre-emptive attack against the development of resistance to breast cancer treatments.
697522
If its latest drug isn't approved, the pharmaceutical could face trouble.
148195
The supply of low-cost generic versions of cancer and AIDS treatments for the developing world could be blocked if Novartis wins a legal challenge to Indiaâs patent law.
451154
A drug approved last year as a last-ditch hope for some lung cancer patients who didn&#39;t find relief from other forms of therapy has come up short in a large clinical trial.
550204
CHICAGO/NEW YORK  - When it comes to the price tag  for the newest biotechology drugs for cancer and other  hard-to-treat diseases, the sky is likely to remain the limit,  insurers, drugmakers and industry watchers say.
602881
Men with prostate cancer who have to wait up to three months after diagnosis to receive external-beam radiation therapy don&#39;t have worse outcomes than men who start treatment
606459
Genentech said that approval of its colon cancer drug Avastin as a treatment for breast cancer would be delayed by at least a year.
208932
GlaxoSmithKline Plc's cervical cancer vaccine Cervarix faces a delay in winning approval in the United States, putting it further behind Merck & Co Inc's rival product Gardasil.
472584
NEW YORK - In a capstone to the withdrawal of Vioxx, the US Food and Drug Administration has decided to delay the approval of successor drug Arcoxia until more safety data are available.